Mitochondrial Therapeutics for Neurological Diseases

a solution to mitochondrial dysfunction

Medication-Resistant Epilepsy Affects 1 Million Patients in the U.S.

That’s where Neuroene Therapeutics comes in.

Innovative
Patented treatment for several disease indications including epilepsy, Parkinson’s, and rare mitochondrial disorders.
Learn more

Validated
Proprietary VK analogs are orally bioavailable, well tolerated, have excellent brain penetration and half-life.
Learn more

Trusted
Our management and advisory team have achieved countless accolades and recognition in their respective specialties.
Learn more

Mitochondria

New Mechanisms of Action

Critical Need for Neurological Diseases Treatments

Neurological diseases are diverse. However, a common trait of many neurological diseases is mitochondrial dysfunction. Neuroene Therapeutics has identified a novel class of compounds based on naturally occurring VK whose central naphthoquinone moiety targets mitochondrial health and energetics. There is a significant unmet need across a wide variety of neurological diseases for such a platform.

©2021 Neuroene Therapeutics. All rights reserved.

Disclaimer: All information provided by Neuroene Therapeutics is for educational purposes only. It is not intended to be used for diagnosing purposes or medical advice. Although Neuroene Therapeutics makes a reasonable effort to present current and accurate data, we disclaim any warranty, expressed or implied.